MEPE-Derived ASARM Peptide Inhibits Odontogenic Differentiation of Dental Pulp Stem Cells and Impairs Mineralization in Tooth Models of X-Linked Hypophosphatemia

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Salmon, Benjamin ^a,b   Bardet, Claire ^a   Khaddam, Mayssam ^a   Naji, Jiar ^a   Coyac, Benjamin R ^a,b,i   Baroukh, Brigitte ^a   Letourneur, Franck ^c   Lesieur, Julie ^a   Decup, Franck ^a,e   Le Denmat, Dominique ^a   Nicoletti, Antonino ^j,k   Poliard, Anne ^a   Rowe, Peter S ^d   Huet, Eric ^f   Vital, Sibylle Opsahl ^a,b   Linglart, Agnès ^b,g,h   McKee, Marc D ⁱ   Chaussain, Catherine ^a,b  

^a France   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSTITUT COCHIN   (France)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e AP HP Odontology Department Charles Foix   (France)

^f CNRS ^*  (France)

^g Bicêtre Paris Sud Hospital   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ MCGILL UNIVERSITY   (Canada)

^j INSERM   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CELL MARKER; COLLAGEN TYPE 1; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; MESSENGER RNA; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MINERALIZATION; CELL ASSAY; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ODONTOBLAST; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; STEM CELL; TOOTH DEVELOPMENT; TOOTH DISEASE; TOOTH PULP; UPREGULATION; X LINKED HYPOPHOSPHATEMIC RICKETS;

ADOLESCENT; ADULT; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DENTAL PULP; FAMILIAL HYPOPHOSPHATEMIC RICKETS; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; ODONTOBLASTS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; YOUNG ADULT;

EID: 84874340085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056749     Document Type: Article

References (66)

1. Gorski JP, (2011) Biomineralization of bone: a fresh view of the roles of non-collagenous proteins. Front Biosci 16: 2598-2621.
2. Opsahl Vital S, Gaucher C, Bardet C, Rowe PS, George A, et al. (2012) Tooth dentin defects reflect genetic disorders affecting bone mineralization. Bone 50: 989-997.
3. Chaussain-Miller C, Sinding C, Wolikow M, Lasfargues JJ, Godeau G, et al. (2003) Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D. J Pediatr. 142: 324-331.
4. Seow WK, Needleman HL, Holm IA, (1995) Effect of familial hypophosphatemic rickets on dental development: a controlled, longitudinal study. Pediatr Dent 17: 346-350.
5. Seow WK, (1984) X-linked hypophosphataemic vitamin D-resistant rickets. Aust Dent J 29: 371-377.
6. Chaussain-Miller C, Sinding C, Septier D, Wolikow M, Goldberg M, et al. (2007) Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. Oral Dis 13: 482-489.
7. Boukpessi T, Septier D, Bagga S, Garabedian M, Goldberg M, et al. (2006) Dentin alteration of deciduous teeth in human hypophosphatemic rickets. Calcif Tissue Int 79: 294-300.
8. Murayama T, Iwatsubo R, Akiyama S, Amano A, Morisaki I, (2000) Familial hypophosphatemic vitamin D-resistant rickets: dental findings and histologic study of teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90: 310-316.
9. Fisher LW, Fedarko NS, (2003) Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 44 (Suppl 1): 33-40.
10. Qin C, Baba O, Butler WT, (2004) Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 15: 126-136.
11. Suzuki S, Haruyama N, Nishimura F, Kulkarni AB (2012) Dentin sialophosphoprotein and dentin matrix protein-1: Two highly phosphorylated proteins in mineralized tissues. Arch Oral Biol.
12. Boukpessi T, Gaucher C, Leger T, Salmon B, Le Faouder J, et al. (2010) Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin. Am J Pathol 177: 803-812.
13. Gaucher C, Boukpessi T, Septier D, Jehan F, Rowe PS, et al. (2009) Dentin noncollagenous matrix proteins in familial hypophosphatemic rickets. Cells Tissues Organs 189: 219-223.
14. Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, et al. (2008) Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 149: 1757-1772.
15. David V, Martin A, Hedge AM, Rowe PS, (2009) Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology 150: 4012-4023.
16. Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, et al. (2000) MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 67: 54-68.
17. Boskey AL, Chiang P, Fermanis A, Brown J, Taleb H, et al. (2010) MEPE's diverse effects on mineralization. Calcif Tissue Int 86: 42-46.
18. Rowe PS, (2012) Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway. Crit Rev Eukaryot Gene Expr 22: 61-86.
19. Staines KA, Mackenzie NC, Clarkin CE, Zelenchuk L, Rowe PS, et al. (2012) MEPE is a novel regulator of growth plate cartilage mineralization. Bone 51: 418-430.
20. Argiro L, Desbarats M, Glorieux FH, Ecarot B, (2001) Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 74: 342-351.
21. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, et al. (2003) Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278: 1998-2007.
22. Quarles LD, (2003) FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285: E1-9.
23. Rowe PS, Kumagai Y, Gutierrez G, Garrett IR, Blacher R, et al. (2004) MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 34: 303-319.
24. Rowe PS, Garrett IR, Schwarz PM, Carnes DL, Lafer EM, et al. (2005) Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone 36: 33-46.
25. Rowe PS, Oudet CL, Francis F, Sinding C, Pannetier S, et al. (1997) Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet 6: 539-549.
26. Gaucher C, Walrant-Debray O, Nguyen TM, Esterle L, Garabedian M, et al. (2009) PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet 125: 401-411.
27. Lorenz-Depiereux B, Guido VE, Johnson KR, Zheng QY, Gagnon LH, et al. (2004) New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice. Mamm Genome 15: 151-161.
28. Filisetti D, Ostermann G, von Bredow M, Strom T, Filler G, et al. (1999) Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues. Eur J Hum Genet 7: 615-619.
29. Econs MJ, Friedman NE, Rowe PS, Speer MC, Francis F, et al. (1998) A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 83: 3459-3462.
30. Rowe PS, (2004) The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med 15: 264-281.
31. David V, Martin A, Hedge AM, Drezner MK, Rowe PS, (2011) ASARM peptides: PHEX-dependent and-independent regulation of serum phosphate. Am J Physiol Renal Physiol 300: F783-791.
32. Addison WN, Masica DL, Gray JJ, McKee MD, (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25: 695-705.
33. Addison WN, Nakano Y, Loisel T, Crine P, McKee MD, (2008) MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 23: 1638-1649.
34. Rowe PS, (2012) The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled. Cell Biochem Funct 30: 355-375.
35. Martin A, David V, Quarles LD, (2012) Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 92: 131-155.
36. Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, et al. (2012) Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia. J Bone Miner Res.
37. Liu S, Rowe PS, Vierthaler L, Zhou J, Quarles LD, (2007) Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity. J Endocrinol 192: 261-267.
38. Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, et al. (2011) Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 26: 1425-1436.
39. Six N, Septier D, Chaussain-Miller C, Blacher R, DenBesten P, et al. (2007) Dentonin, a MEPE fragment, initiates pulp-healing response to injury. J Dent Res 86: 780-785.
40. Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, et al. (2003) SHED: stem cells from human exfoliated deciduous teeth. Proceedings of the National Academy of Sciences of the United States of America 100: 5807-5812.
41. Cordeiro MM, Dong Z, Kaneko T, Zhang Z, Miyazawa M, et al. (2008) Dental pulp tissue engineering with stem cells from exfoliated deciduous teeth. J Endod 34: 962-969.
42. Rajan N, Habermehl J, Cote MF, Doillon CJ, Mantovani D, (2006) Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nat Protoc 1: 2753-2758.
43. Huang GT, Yamaza T, Shea LD, Djouad F, Kuhn NZ, et al. (2010) Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A 16: 605-615.
44. Baroukh B, Cherruau M, Dobigny C, Guez D, Saffar JL, (2000) Osteoclasts differentiate from resident precursors in an in vivo model of synchronized resorption: a temporal and spatial study in rats. Bone 27: 627-634.
45. Roche PC, Ryan RJ, McCormick DJ, (1992) Identification of hormone-binding regions of the luteinizing hormone/human corionic gonadotropin receptor using synthetic peptides. Endocrinology 131: 268-274.
46. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
47. Chaussain C, Eapen AS, Huet E, Floris C, Ravindran S, et al. (2009) MMP2-cleavage of DMP1 generates a bioactive peptide promoting differentiation of dental pulp stem/progenitor cell. Eur Cell Mater 18: 84-95.
48. Bell E, Ivarsson B, Merrill C, (1979) Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A 76: 1274-1278.
49. Ortinau S, Schmich J, Block S, Liedmann A, Jonas L, et al. (2010) Effect of 3D-scaffold formation on differentiation and survival in human neural progenitor cells. Biomed Eng Online 9: 70.
50. Estes BT, Guilak F, (2011) Three-dimensional culture systems to induce chondrogenesis of adipose-derived stem cells. Methods Mol Biol 702: 201-217.
51. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S, (2000) Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97: 13625-13630.
52. Coulomb B, Dubertet L, Merrill C, Touraine R, Bell E, (1984) The collagen lattice: a model for studying the physiology, biosynthetic function and pharmacology of the skin. Br J Dermatol 111 (Suppl 27): 83-87.
53. Pedraza CE, Marelli B, Chicatun F, McKee MD, Nazhat SN, (2010) An in vitro assessment of a cell-containing collagenous extracellular matrix-like scaffold for bone tissue engineering. Tissue Eng Part A 16: 781-793.
54. Szpalski C, Wetterau M, Barr J, Warren SM (2011) Bone Tissue Engineering: Current Strategies and Techniques Part I-Scaffolds. Tissue Eng Part B Rev.
55. Wang J, Ma H, Jin X, Hu J, Liu X, et al. (2011) The effect of scaffold architecture on odontogenic differentiation of human dental pulp stem cells. Biomaterials 32: 7822-7830.
56. Kerkis I, Caplan AI, (2012) Stem cells in dental pulp of deciduous teeth. Tissue Eng Part B Rev 18: 129-138.
57. Arnold WH, Gaengler P, (2007) Quantitative analysis of the calcium and phosphorus content of developing and permanent human teeth. Ann Anat 189: 183-190.
58. Mishima H, Kozawa Y, (1998) SEM and EDS analysis of calcospherites in human teeth. Eur J Oral Sci 106 (Suppl 1): 392-396.
59. Barragan-Adjemian C, Nicolella D, Dusevich V, Dallas MR, Eick JD, et al. (2006) Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone. Calcif Tissue Int 79: 340-353.
60. Sakai VT, Cordeiro MM, Dong Z, Zhang Z, Zeitlin BD, et al. (2011) Tooth slice/scaffold model of dental pulp tissue engineering. Adv Dent Res 23: 325-332.
61. Bresler D, Bruder J, Mohnike K, Fraser WD, Rowe PS, (2004) Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets. J Endocrinol 183: R1-9.
62. Millan JL, (2006) Alkaline Phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2: 335-341.
63. Bitar M, Brown RA, Salih V, Kidane AG, Knowles JC, et al. (2008) Effect of cell density on osteoblastic differentiation and matrix degradation of biomimetic dense collagen scaffolds. Biomacromolecules 9: 129-135.
64. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL, (2011) A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res 26: 1381-1388.
65. Liu H, Li W, Shi S, Habelitz S, Gao C, et al. (2005) MEPE is downregulated as dental pulp stem cells differentiate. Arch Oral Biol 50: 923-928.
66. Wang H, Kawashima N, Iwata T, Xu J, Takahashi S, et al. (2010) Differentiation of odontoblasts is negatively regulated by MEPE via its C-terminal fragment. Biochem Biophys Res Commun 398: 406-412.